Mid-Atlantic Retina Consultations, Inc. Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3
Founded: Morgantown WV United States (2006)

Organization Overview

First Clinical Trial
2006
NCT00570193
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

MidAtlantic Retina

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Choroidal Neovascularization (Phase 2)

Diabetic Angiopathies (Phase 1)

Edema (Phase 2)

Macular Degeneration (Phase 3)

Macular Edema (Phase 2)

Neovascularization, Pathologic (Phase 2)

Retinal Vein Occlusion (Phase 2)

Vascular Diseases (Phase 1)

Wet Macular Degeneration (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 11
  • # of Trial APIs: 21